PNPLA3 and steatosis: We observed genotype-specific differences in response to resmetirom consistent with this, demonstrating that steatosis, stellate cell activation, and secretion of the pro-fibrotic marker COL1A1 were significantly reduced in the PNPLA3 wild-type LAMPS compared to the GG LAMPS.